A recent study suggests that individuals who come off blockbuster slimming jabs like Wegovy and Mounjaro can put back on shed pounds far faster than those who stop conventional lifestyle programs.
Research printed in a leading health publication points out that while overweight people often shed a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"People buying these drugs need to be aware of the risk of rapid weight regain when the medication ends," stated lead investigator Dr. Susan Jebb.
This pace of regain implies a reversion to pre-treatment mass within about one and a half years.
Comparing Therapies
The analysis, which reviewed dozens of studies involving over 9,000 of participants, contrasted the outcomes of these new drugs with other pills.
The team emphasize that individuals who lose weight through diet and exercise typically experience a slower weight regain—approximately 0.1 kg a month—after stopping.
Explaining the Quick Rebound
Nutrition scientists propose the way of the drugs is key to understanding the amplified regain.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone concentrations far above than normal could lead to the body to generate a reduced amount of its own natural hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication means hunger is no longer kept in check, making overeating far more likely."
An Ongoing Disease?
Health authorities recommend the jabs for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.
Many experts argue that, given the likelihood of relapse, the treatment is often long-term.
This perspective is supported by pharmaceutical companies, who say that the findings "underscore the chronic nature of excess weight," comparing it to managing diseases like hypertension.
User Accounts
People who have discontinued the medication describe a powerful resurgence of hunger.
"I experienced a switch flipping and you become starving," said a patient.
This challenge is worsened if individuals have not developed permanent lifestyle or habit changes during therapy.
Growing Use
Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand continuing to grow.
- Use is higher among women compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, researchers emphasize that while GLP-1 drugs are potent agents for shedding pounds, they are not a magic solution and long-term success likely depends on integrated lifestyle support.
